View publication

↩ Back to all publications
Publication
PropertyValue
Working Groups RG Griesinger
SubprojectRA2.2
Open AccessOpen Access Yes
Publication TypeJournal Article
PMIDPubMed ID 35500536
DOIDOI 10.1016/j.ebiom.2022.104021
Publication Year2022
TitleSafety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
JournaleBioMedicine
ISSN2352-3964
ESSN2352-3964
URL http://dx.doi.org/10.1016/j.ebiom.2022.104021
Pages104021
Volume80
Journal AbbreviationeBioMedicine
AuthorsLevin J, Sing N, Melbourne S, Morgan A, Mariner C, Spillantini MG, Wegrzynowicz M, Dalley JW, Langer S, Ryazanov S, Leonov A, Griesinger C, Schmidt F, Weckbecker D, Prager K, Matthias T, Giese A
First AuthorLevin J
Last AuthorGiese A

 External Resources

 thelance...0205-5  Article fulltext

 gro-2/108672  GRO.publications identifier

 9606  NCBI taxonomy (human, Homo sapiens)

 0000-0002-1266-4344  ORCID identifier (Christian Griesinger)

 1/56  Research Data Archive (supplemental material)

 03e76ya46  ROR identifier (03e76ya46, Max Planck Institute for Biophysical Chemistry)

 05xy1nn52  ROR identifier (05xy1nn52, Multiscale Bioimaging)

 SCR_003751  SciCrunch identifier (RRID:SCR_003751, Medical Dictionary for Regulatory Activities )

 SCR_008567  SciCrunch identifier (RRID:SCR_008567, Statistical Analysis System)

 thelance...1.docx  Supplemental material

 thelance...2.pptx  Supplemental material

 mbexc.de...ebo-c/  Website entry (mbexc.de)